Rtw Investments, LP Fulcrum Therapeutics, Inc. Transaction History

Rtw Investments, LP

$5.99 Billion
Q2 2024

A detailed history of Rtw Investments, LP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 5,845,956 shares of FULC stock, worth $18.8 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

5,845,956

Previous 5,845,956 -0.0%

Holding current value

$18.8 Million

Previous $55.2 Million 34.32%

% of portfolio

0.61%

Previous 0.89%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.7 - $12.0 $2.52 Million - $4.51 Million	376,000 Added 6.87%	5,845,956 $55.2 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $1.11 Million - $2.39 Million	-348,848 Reduced 6.0%	5,469,956 $36.9 Million
Q3 2023 Nov 14, 2023	SELL	$3.25 - $6.08 $797,286 - $1.49 Million	-245,319 Reduced 4.05%	5,818,804 $25.8 Million
Q2 2023 Aug 14, 2023	BUY	$2.26 - $3.8 $1.25 Million - $2.1 Million	552,284 Added 10.02%	6,064,123 $20 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $1.47 Million - $7.25 Million	518,560 Added 10.39%	5,511,839 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $5.05 Million - $8.41 Million	1,007,369 Added 25.27%	4,993,279 $36.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $121,602 - $224,915	24,716 Added 0.62%	3,985,910 $32.2 Million
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $1.47 Million - $8.4 Million	350,000 Added 9.69%	3,961,194 $19.4 Million
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $2.55 Million - $6.05 Million	-255,678 Reduced 6.61%	3,611,194 $85.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $162,134 - $329,363	11,581 Added 0.3%	3,866,872 $68.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $4.73 Million - $20.1 Million	650,000 Added 20.28%	3,855,291 $109 Million
Q1 2021 May 14, 2021	BUY	$10.94 - $15.32 $12.4 Million - $17.4 Million	1,133,882 Added 54.74%	3,205,291 $37.8 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $7.22 Million - $12.3 Million	920,844 Added 80.03%	2,071,409 $24.3 Million
Q3 2020 Nov 16, 2020	BUY	$7.22 - $20.7 $8.31 Million - $23.8 Million	1,150,565 New	1,150,565 $9.12 Million

Others Institutions Holding FULC

# of Institutions

138

Shares Held

59.3M

Call Options Held

4.33M

Put Options Held

309K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $167M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Fulcrum Therapeutics, Inc. Transaction History